At Secret Saviours, we believe in 100% transparency. No gimmicks, no smoke and mirrors, no tricks. Just facts and real results.
That's why we make information from our trial available for you to read either on our website, or even to download and keep for yourself.
In our independent clinical trial around 70% (66% to be precise) of users didn’t get stretch marks and 20% had less severe stretch marks because they used Secret Saviours (we know this because we can compare them against the group who didn’t use our system).
We also found out that 1 in every 10 women will get severe stretch marks whatever they do to prevent them. And we identified a group of women who really don’t need to use stretch mark prevention products because they just won’t get them – the problem is you’ll never know if that is you! But we do know that if you use Secret Saviours daily throughout your pregnancy you will double your chances of avoiding stretch marks.
If you’re one for statistics we’ve simplified the results in the table below. Or you can read about the validity of our clinical trial here.
Terrie pushed her skin to the limit whilst carrying her twins but look, no stretch marks!
No Stretch Marks
| Got Stretch Marks
| Severity of stretch marks
(score 0- low and 10 – high) | |
---|---|---|---|
Trial group (who used Secret Saviours throughout their pregnancy) | 66% | 34% | 24% - 0 and 10% 10 |
Control group (who did not use Secret Saviours during their pregnancy)
| 34% | 66% | 56% - 4 and 10% - 10 |
Conclusion | Secret Saviours reduced the incidence of stretch marks by 50%
| 20% of women had less severe stretch marks because they used Secret Saviours
|
In summary our inventor Stephen Barker says “ The clinical trial proved unequivocally that if you use Secret Saviours daily throughout your pregnancy you will double your chances of avoiding stretch marks.
Click here to read the full clinical trial.
If you have any further questions about stretch marks, please email Dr Stephen (drstephen@secretsaviours.com)
The clinical trial was coordinated by a US-based associate professor of surgery, liaising with a lead Consultant Obstetrician at the Instituto de Maternidad y Ginecologia in Tucuman, Argentina. Six additional Consultant Obstetricians recruited patients in to the trial, over a 16-month period, following Ethics Committee approval to commence the study.
A Consultant Dermatologist, a dermatology research fellow, a Consultant Surgeon, a surgical research fellow, a PhD scientist and a Consultant Obstetrician judged the results which were collated by an independent medical statistician.